Wolverine Trading’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 1978 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 2036 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 2112 |
|
2024
Q3 | – | Sell |
-3,915
| Closed | -$539K | – | 1927 |
|
2024
Q2 | $539K | Sell |
3,915
-2,945
| -43% | -$405K | ﹤0.01% | 620 |
|
2024
Q1 | $946K | Buy |
+6,860
| New | +$946K | ﹤0.01% | 419 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 1873 |
|
2022
Q2 | – | Sell |
-4,768
| Closed | -$441K | – | 1938 |
|
2022
Q1 | $441K | Buy |
+4,768
| New | +$441K | ﹤0.01% | 813 |
|
2021
Q4 | – | Sell |
-4,537
| Closed | -$428K | – | 2333 |
|
2021
Q3 | $428K | Buy |
4,537
+1,518
| +50% | +$143K | ﹤0.01% | 1091 |
|
2021
Q2 | $293K | Buy |
3,019
+461
| +18% | +$44.7K | ﹤0.01% | 1251 |
|
2021
Q1 | $241K | Sell |
2,558
-3,287
| -56% | -$310K | ﹤0.01% | 1378 |
|
2020
Q4 | $558K | Sell |
5,845
-567
| -9% | -$54.1K | ﹤0.01% | 785 |
|
2020
Q3 | $626K | Buy |
+6,412
| New | +$626K | ﹤0.01% | 562 |
|
2020
Q2 | – | Sell |
-8,352
| Closed | -$765K | – | 1775 |
|
2020
Q1 | $765K | Buy |
+8,352
| New | +$765K | ﹤0.01% | 482 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 1795 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 1722 |
|
2019
Q1 | – | Sell |
-4,660
| Closed | -$319K | – | 1759 |
|
2018
Q4 | $319K | Sell |
4,660
-6,940
| -60% | -$475K | ﹤0.01% | 828 |
|
2018
Q3 | $1.43M | Buy |
+11,600
| New | +$1.43M | ﹤0.01% | 393 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 1754 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 1919 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1919 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 1712 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 1700 |
|
2017
Q1 | – | Sell |
-17,389
| Closed | -$673K | – | 1720 |
|
2016
Q4 | $673K | Buy |
+17,389
| New | +$673K | ﹤0.01% | 462 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 1668 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 1258 |
|